- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT03427645
Development of a Tailored Life-Sustaining Treatment Decision Support Intervention for Stroke Surrogate Decision Makers
The trial is testing an investigator-developed decision support tool for surrogate decision makers for stroke patients that are unable to make medical decisions for themselves.
A historical usual care control group will be enrolled during tool development. The tool will then be tested in surrogates of hospitalized stroke patients.
Studienübersicht
Detaillierte Beschreibung
Decision support tools, specifically recommended in the 2010 Affordable Care Act, have been shown to improve the quality of decisions and reduce burden on the decision maker in multiple clinical settings, yet almost none have focused on life-sustaining treatments in acute critical illness such as stroke. This study proposes a comprehensive frame shift in how the health care team and surrogates collaborate on decisions regarding life-sustaining treatments for acute illness, by developing a tailored web-based stroke decision support intervention. This web-based tool will be developed for use by the surrogate decision maker during the acute stroke hospitalization and will be designed to facilitate high quality patient-centered decisions and minimize adverse effects on the surrogate.
The two project phases are: 1) Decision support intervention development; and 2) Pilot testing in surrogates of hospitalized stroke patients. A novel ordinal prognostic model will be developed and incorporated into the tool.
The project expects 25 surrogate-patient pairs in the control group, and 25 surrogate-patient pairs in the intervention group, which equals a total of 100 subjects.
Studientyp
Einschreibung (Tatsächlich)
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
Michigan
-
Ann Arbor, Michigan, Vereinigte Staaten, 48109
- The University of Michigan
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Surrogates:
Inclusion Criteria:
- Self-identify as the surrogate decision maker for eligible patient
- Able to read and communicate in English without an interpreter
- Limited to one surrogate per patient
Exclusion Criteria:
- No prior relationship with patient
- Dementia or other cognitive or health condition that would impair their ability to participate
Patients:
Inclusion Criteria:
- Ischemic stroke or spontaneous intracerebral hemorrhage
- Impaired decisional capacity (per treating team)
- Enrolled on or before full hospital day 5
Minimum illness severity (either):
- National Institutes of Health Stroke Scale ≥ 10
- Glasgow coma scale ≤12
Exclusion Criteria:
- No surrogate available for study procedures
- Already on comfort measures only
- Physician refuses to allow approach for consent
- Pregnancy
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Versorgungsforschung
- Zuteilung: Nicht randomisiert
- Interventionsmodell: Einzelgruppenzuweisung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
---|---|
Kein Eingriff: Control Surrogate Arm
Usual care control group will complete baseline and follow-up questionnaires with standard decision making techniques.
This group will not be asked to use the decision making tool.
|
|
Experimental: Surrogate Decision Tool Arm
This group will complete a baseline questionnaire, then use the tool and complete follow up questionnaires.
|
A tailored web-based stroke decision support intervention.
This web-based tool will be developed for use by the surrogate decision maker during the acute stroke hospitalization and will be designed to facilitate high quality patient-centered decisions and minimize adverse effects on the surrogate.
Andere Namen:
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Acceptability of the decision tool intervention
Zeitfenster: Immediately post-intervention
|
The proportion of cases where the surrogate completes use of the tool with high acceptability using the Acceptability E-Scale.
The Acceptability E-Scale is a 6-item scale.
A score of 1 indicates a negative evaluation and 5 indicates a positive evaluation.
A score of 3 indicates a neutral evaluation.
An individual will be considered to have high acceptability if the average response across the 6 items is 4 or higher)
|
Immediately post-intervention
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Accuracy of the surrogate's prognostic estimate for functional recovery
Zeitfenster: Within approximately 5 days of admission
|
Calculated as the absolute value of the difference between the surrogate's estimate of the probability (0-100%) of return to functional independence by 90 days and the model based estimate of modified Rankin of 0-2.
Range of this measure will be 0-100.
|
Within approximately 5 days of admission
|
Decisional Self Efficacy scale
Zeitfenster: Within approximately 5 days of admission
|
11-item scale (a score of 0 indicates not at all confident and a 4 indicates very confident) with ordered categorical responses, converted to a 0-100 scale based on the average of the responses to each item.
A score of 0 means extremely low self-efficacy and a score of 100 means extremely high self-efficacy
|
Within approximately 5 days of admission
|
Mitarbeiter und Ermittler
Sponsor
Mitarbeiter
Ermittler
- Hauptermittler: Darin Zahuranec, University of Michigan
Publikationen und hilfreiche Links
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- HUM00118298
- 1R21NR016332-01A1 (US NIH Stipendium/Vertrag)
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Decision tool
-
University of California, San FranciscoAbgeschlossenNephrolithiasisVereinigte Staaten
-
Columbia UniversityNational Heart, Lung, and Blood Institute (NHLBI)RekrutierungDepressive Symptome | Koronare HerzerkrankungVereinigte Staaten
-
University of FloridaRekrutierungTelemedizin | PädiatrieHaiti
-
Milton S. Hershey Medical CenterEunice Kennedy Shriver National Institute of Child Health and Human Development... und andere MitarbeiterAbgeschlossen
-
Karolinska InstitutetRegion StockholmRekrutierung
-
University of Maryland, BaltimoreEunice Kennedy Shriver National Institute of Child Health and Human Development... und andere MitarbeiterAktiv, nicht rekrutierendGrampositive bakterielle Infektionen | Pharmakokinetik | Pharmakodynamik | VancomycinVereinigte Staaten
-
University of California, San FranciscoNational Institute on Minority Health and Health Disparities (NIMHD); Florida...RekrutierungSexuell übertragbare Krankheiten | Menschlicher Immunschwächevirus | Übertragung des Human Immunodeficiency VirusVereinigte Staaten
-
Children's Hospital Medical Center, CincinnatiAbgeschlossenColitis ulcerosa, KinderVereinigte Staaten
-
Temple UniversityNational Institute of Mental Health (NIMH)AbgeschlossenPsychotische StörungenVereinigte Staaten
-
Northwestern UniversityUniversity of California, Los Angeles; National Institute on Aging (NIA); University... und andere MitarbeiterAnmeldung auf EinladungPolypharmazieVereinigte Staaten